Zobrazeno 1 - 10
of 26
pro vyhledávání: '"N, Neyrolles"'
Publikováno v:
La Revue de Médecine Interne. 20:351s-359s
Resume L’anomalie fonctionnelle de la cellule β represente l’une des cibles therapeutiques majeures dans le traitement du diabete de type 2. Parmi les antidiabetiques oraux actuellement disponibles, seuls les sulfamides hypoglycemiants sont doue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0197f85a497ef25bb352c1b14097db8
https://doi.org/10.1016/s0248-8663(99)80508-6
https://doi.org/10.1016/s0248-8663(99)80508-6
Publikováno v:
La Revue de Médecine Interne. 20:371s-378s
The relief of insulin resistance is one of the two therapeutic targets of the treatment of type 2 diabetes. Insulin-sensitizers are therefore complemental with other oral diabetic drugs. The treatment of insulin resistance was for a long time limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::270066122df7842ca60405f0d08bedd5
https://doi.org/10.1016/s0248-8663(99)80510-4
https://doi.org/10.1016/s0248-8663(99)80510-4
Publikováno v:
Revue neurologique. 157(8-9 Pt 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f84976e7ca67672dc12d14ab8246e146
https://pubmed.ncbi.nlm.nih.gov/11677411
https://pubmed.ncbi.nlm.nih.gov/11677411
Publikováno v:
La Revue de medecine interne. 20
The relief of insulin resistance is one of the two therapeutic targets of the treatment of type 2 diabetes. Insulin-sensitizers are therefore complemental with other oral diabetic drugs. The treatment of insulin resistance was for a long time limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::594df8ed8447f44ac1ee1dfeda8c72dd
https://pubmed.ncbi.nlm.nih.gov/10480188
https://pubmed.ncbi.nlm.nih.gov/10480188
Publikováno v:
La Revue de medecine interne. 20
The functional defect of the pancreatic beta cell represents one of the main therapeutic targets in type 2 diabetes mellitus. Among the currently available oral antidiabetic drugs, only hypoglycaemic sulfonylureas exhibit beta cell stimulating proper
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::083323cceba2e381977e2441ceaf6892
https://pubmed.ncbi.nlm.nih.gov/10480186
https://pubmed.ncbi.nlm.nih.gov/10480186
Publikováno v:
La Revue de medecine interne. 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::015140b30a13d9bc17db4c313bcd01ad
https://pubmed.ncbi.nlm.nih.gov/10422177
https://pubmed.ncbi.nlm.nih.gov/10422177
Publikováno v:
Annales d'endocrinologie. 59(2)
The progress of knowledge relating to non-insulin-dependent diabetes mellitus (NIDDM) is associated with new therapeutic developments. Their different respective targets allow to classify them in drugs stimulating insulin secretion (glimepiride, repa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b0939b6743b432bc8401971b65b37d5a
https://pubmed.ncbi.nlm.nih.gov/9789590
https://pubmed.ncbi.nlm.nih.gov/9789590
Publikováno v:
La Revue de Médecine Interne. 20:297s-298s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::281a84be954d3eb287cb086402de018a
https://doi.org/10.1016/s0248-8663(99)80472-x
https://doi.org/10.1016/s0248-8663(99)80472-x
Publikováno v:
La Revue de Médecine Interne. 18:s328-s329
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b01ce82af34e1dc7aba7ba4dd6e9ad82
https://doi.org/10.1016/s0248-8663(97)80597-8
https://doi.org/10.1016/s0248-8663(97)80597-8
Publikováno v:
La Revue de Médecine Interne. 18:530s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a17f5ee205f12dfbbc5e97b695a3cd6b
https://doi.org/10.1016/s0248-8663(97)80056-2
https://doi.org/10.1016/s0248-8663(97)80056-2